Presentation TCT 2012 TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial Presenter: Gregg Stone October 23, 2012 REGISTER for free or LOG IN to view this content CAD Pharma ACS/AMI Presentation TCT 2012 Up Next Presentation TCT 2012 TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder Presenter: Ignacio Cruz-Gonz?lez October 23, 2012 More slides + Presentation TCT 2012 TCT-95. Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial Presenter: Mathew Williams October 23, 2012 Presentation TCT 2012 TCT-102. Transapical Aortic Valve Implantation: 6 and 12 Months Results from a Multicenter Study Using the JenaValve Second Generation Transcatheter Aortic Valve Implantation... Presenter: Hendrik Treede October 23, 2012 We Recommend
Presentation TCT 2012 TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder Presenter: Ignacio Cruz-Gonz?lez October 23, 2012
Presentation TCT 2012 TCT-95. Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial Presenter: Mathew Williams October 23, 2012
Presentation TCT 2012 TCT-102. Transapical Aortic Valve Implantation: 6 and 12 Months Results from a Multicenter Study Using the JenaValve Second Generation Transcatheter Aortic Valve Implantation... Presenter: Hendrik Treede October 23, 2012